Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

Publisher Name :
Date: 23-May-2019
No. of pages: 235
Inquire Before Buying

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019, provides an overview of the Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline landscape.

H1N1 Infection also called as swine flu is a new kind of flu in humans. It's caused by a contagious virus. H1N1 flu infects the breathing tubes in nose, throat, and lungs. The disease is contagious. When people who have it cough or sneeze, they spray tiny drops of the virus into the air. Signs and symptoms include cough, fever, sore throat, stuffy or runny nose, body aches, headache and fatigue. Treatment includes medication (antiviral drugs).

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Influenza A Virus, H1N1 Subtype Infections (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Influenza A Virus, H1N1 Subtype Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 4, 7, 12, 5, 48, 7 and 1 respectively. Similarly, the Universities portfolio in Phase III, Phase I, Preclinical and Discovery stages comprises 3, 2, 12 and 2 molecules, respectively.

Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Influenza A Virus, H1N1 Subtype Infections (Infectious Disease).

- The pipeline guide reviews pipeline therapeutics for Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Influenza A Virus, H1N1 Subtype Infections (Infectious Disease)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Influenza A Virus, H1N1 Subtype Infections (Infectious Disease).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Influenza A Virus, H1N1 Subtype Infections (Infectious Disease) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

Table of Contents
Introduction
Influenza A Virus, H1N1 Subtype Infections - Overview
Influenza A Virus, H1N1 Subtype Infections - Therapeutics Development
Influenza A Virus, H1N1 Subtype Infections - Therapeutics Assessment
Influenza A Virus, H1N1 Subtype Infections - Companies Involved in Therapeutics Development
Influenza A Virus, H1N1 Subtype Infections - Drug Profiles
Influenza A Virus, H1N1 Subtype Infections - Dormant Projects
Influenza A Virus, H1N1 Subtype Infections - Discontinued Products
Influenza A Virus, H1N1 Subtype Infections - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by AbbVie Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Adimmune Corp, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Akshaya Bio Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Alla Chem LLC, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Allergy Therapeutics Plc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Altimmune Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Amarillo Biosciences Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by AstraZeneca Plc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Beijing Minhai Biotechnology Co Ltd, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by BlueWillow Biologics Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by BunyaVax BV, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by CEL-SCI Corp, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Cidara Therapeutics Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Cilian AG, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Cocrystal Pharma Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by ContraFect Corp, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Curevac AG, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Emergent BioSolutions Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by EpiVax Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Etubics Corp, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by FluGen Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Genentech Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by GlaxoSmithKline Plc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Greffex Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Jiangsu Kanion Pharmaceutical Co Ltd, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Johnson & Johnson, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Kineta Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Kyowa Hakko Kirin Co Ltd, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Medicago Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Microbiotix Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by NanoViricides Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by New Amsterdam Sciences Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Novavax Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by OPKO Health Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by PeptiDream Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Recce Ltd, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Sanofi, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Sanofi Pasteur SA, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Serum Institute of India Ltd, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by TechnoVax Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Touchlight Genetics Ltd, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by UMN Pharma Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Vaccibody AS, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Vaxart Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Visterra Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Pipeline by Vivaldi Biosciences Inc, H1 2019
Influenza A Virus, H1N1 Subtype Infections - Discontinued Products, H1 2019

List of Figures
Number of Products under Development for Influenza A Virus, H1N1 Subtype Infections, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Number of Products by Top 10 Targets, H1 2019
Number of Products by Stage and Top 10 Targets, H1 2019
Number of Products by Top 10 Mechanism of Actions, H1 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
Number of Products by Routes of Administration, H1 2019
Number of Products by Stage and Top 10 Routes of Administration, H1 2019
Number of Products by Top 10 Molecule Types, H1 2019
Number of Products by Stage and Top 10 Molecule Types, H1 2019
  • Global Amoxicillin Market Growth 2021-2026
    Published: 25-Jan-2021        Price: US 3660 Onwards        Pages: 163
    According to this latest study, the 2020 growth of Amoxicillin will have significant change from previous year. By the most conservative estimates of global Amoxicillin market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4454.1 million in 2019. Over the next five years the Amoxicillin market will register a 0.9% CAGR in terms of revenue, the global market size will reach US$ 4622.8 million by 2025. This report presents a comprehe......
  • Global Ampicillin Market Research Report 2021
    Published: 22-Jan-2021        Price: US 2900 Onwards        Pages: 92
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Ampicillin Capsules - Ampicillin Sodium - Ampicillin Granules - Ampicillin Tablets - Ampicill......
  • Azithromycin Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 21-Jan-2021        Price: US 3000 Onwards        Pages: 103
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmen......
  • Global Tigecycline Market Growth 2021-2026
    Published: 21-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Tigecycline will have significant change from previous year. By the most conservative estimates of global Tigecycline market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1002.8 million in 2019. Over the next five years the Tigecycline market will register a 18.6% CAGR in terms of revenue, the global market size will reach US$ 1984.7 million by 2025. This report presents a compreh......
  • Global Drugs For Herpes Labialis (Oral Herpes) Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 21-Jan-2021        Price: US 3500 Onwards        Pages: 130
    Based on the Drugs For Herpes Labialis (Oral Herpes) market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are ......
  • Global Drugs for Toxoplasmosis Market Research Report 2021
    Published: 21-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Injection - Tablet - Others Segment by Application - Chronic Toxoplasmosis Treatment......
  • Amoxicillin Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
    Published: 20-Jan-2021        Price: US 3000 Onwards        Pages: 97
    Summary Further key aspects of the report indicate that: Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology Chapter 2: Global Industry Summary Chapter 3: Market Dynamics Chapter 4: Global Market Segmentation by region, type and End-Use Chapter 5: North America Market Segmentation by region, type and End-Use Chapter 6: Europe Market Segmentation by region, type and End-Use Chapter 7: Asia-Pacific Market Segmen......
  • Global Amoxicillin Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery
    Published: 19-Jan-2021        Price: US 3500 Onwards        Pages: 107
    It is one of the most commonly used semi-synthetic penicillin broad-spectrum ß-lactam antibiotics. It is a white powder. Amoxicillin has strong bactericidal action and strong ability to penetrate cell membrane. Based on the Amoxicillin market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the comp......
  • Global Metronidazole Market Research Report 2021
    Published: 18-Jan-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Glyoxal Process - Ethidene Diamine Process - Others Segment by Application - Metronid......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs